학술논문

Filtration Markers as Predictors of ESRD and Mortality in Southwestern American Indians With Type 2 Diabetes
Document Type
article
Source
American Journal of Kidney Diseases. 66(1)
Subject
Clinical Research
Prevention
Kidney Disease
Diabetes
Adult
Arizona
Biomarkers
Comorbidity
Diabetes Mellitus
Type 2
Diabetic Nephropathies
Disease Progression
Disease Susceptibility
Ethnicity
Female
Follow-Up Studies
Glomerular Filtration Rate
Humans
Hyperlipidemias
Hypertension
Indians
North American
Intramolecular Oxidoreductases
Kaplan-Meier Estimate
Kidney Failure
Chronic
Kidney Glomerulus
Lipocalins
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Risk Factors
beta 2-Microglobulin
Beta-trace protein
beta-2 microglobulin
end-stage renal disease
type 2 diabetes mellitus
diabetic kidney failure
mortality
filtration markers
glomerular filtration rate
kidney function
Pima Indians
CKD Biomarkers Consortium
Clinical Sciences
Public Health and Health Services
Urology & Nephrology
Language
Abstract
© 2015. Background: A growing number of serum filtration markers are associated with mortality and end-stage renal disease (ESRD) in adults. Whether β-trace protein (BTP) and β2-microglobulin (B2M) are associated with these outcomes in adults with type 2 diabetes is not known. Study Design: Longitudinal cohort study. Setting & Participants: 250 Pima Indians with type 2 diabetes (69% women; mean age, 42 years; mean diabetes duration, 11 years). Predictors: Serum BTP, B2M, and glomerular filtration rate measured by iothalamate clearance (mGFR) or estimated using creatinine (eGFRcr) or cystatin C level (eGFRcys). Outcomes & Measurements: Incident ESRD and all-cause mortality through December 2013. HRs were reported per interquartile range decrease of the inverse of BTP and B2M (1/BTP and 1/B2M) using Cox regression. Improvement in risk prediction with the addition of BTP or B2M level to established markers (eGFRcys with mGFR or eGFRcr) was evaluated using C statistics, continuous net reclassification improvement, and relative integrated discrimination improvement (RIDI). Results: During a median follow-up of 14 years, 69 participants developed ESRD and 95 died. Both novel markers were associated with ESRD in multivariable models. BTP level remained statistically significant after further adjustment for mGFR (1/BTP, 1.53 [95% CI, 1.01-2.30]; 1/B2M, 1.54 [95% CI, 0.98-2.42]). B2M level was associated with mortality in multivariable models and after further adjustment for mGFR (HR, 2.12; 95% CI, 1.38-3.26). The addition of B2M level to established markers increased the C statistic for mortality but only weakly when assessed by either continuous net reclassification improvement or RIDI; none was improved for ESRD by the addition of these markers. Limitations: Small sample size, single measurements of markers. Conclusions: In Pima Indians with type 2 diabetes, BTP and, to a lesser extent, B2M levels were associated with ESRD. B2M level was associated with mortality after adjustment for traditional risk factors and established filtration markers. Further studies are warranted to confirm whether inclusion of B2M level in a multimarker approach leads to improved risk prediction for mortality in this population.